Plain-English translation of NCT06066853 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial testing -assisted therapy as a potential treatment for fibromyalgia—a condition that causes widespread chronic pain. Researchers want to understand how this medication works in the brain to relieve pain by using advanced brain imaging technology. The study will enroll 20 people to see if the treatment can reduce pain and how it affects brain function.
Current fibromyalgia treatments don't work well for everyone, and doctors need new options. This research aims to understand whether this medication could be an effective pain relief strategy and to learn exactly how it changes brain activity to reduce suffering.
You likely qualify if…
You likely don't qualify if…
You'll start with a screening visit where staff will review your medical history, run blood tests, check your heart health, and measure how your body responds to pressure pain. If you qualify, you'll attend experimental sessions where you'll receive the medication and undergo brain imaging scans while researchers observe how your brain responds. Throughout the study, you must bring a designated support person to stay with you on treatment evenings, and you'll need to keep taking your current medications at stable doses.
AI-generated summary from trial data · Oct 4, 2026 · Not medical advice
United States